Kempharm Inc buy Quitte
Start price
15.06.16
/
50%
€4.26
Target price
15.12.16
€4.73
Performance (%)
-27.97%
End price
15.12.16
€3.07
Summary
This prediction ended on 15.12.16 with a price of €3.07. The prediction for Kempharm Inc disappointed with a performance of -27.97%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kempharm Inc | - | - | - | - |
| iShares Core DAX® | -5.868% | -2.496% | 2.292% | 50.129% |
| iShares Nasdaq 100 | 1.660% | 3.513% | 13.191% | 88.484% |
| iShares Nikkei 225® | -6.126% | 2.136% | 27.665% | 53.973% |
| iShares S&P 500 | 0.504% | 2.045% | 9.817% | 60.027% |
Comments by Quitte for this prediction
In the thread Kempharm Inc diskutieren
nach dem Absturz ist vor dem Anstieg
Shares of KemPharm Inc. (KMPH) were down over 26% in extended trading on Monday, following the receipt of FDA's complete response letter for the company's New drug Application for Apadaz.
(Laufzeit überschritten)